(Q44925729)

English

A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma

scientific article

Statements

A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma (English)
1 March 2009

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit